Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA

被引:147
作者
Circolo, A
Garnier, G
Fukuda, W
Wang, XF
Hidvegi, T
Szalai, AJ
Briles, DE
Volanakis, JE
Wetsel, RA
Colten, HR
机构
[1] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA
[2] Univ Alabama Birmingham, Sch Med, Dept Med, Birmingham, AL 35294 USA
来源
IMMUNOPHARMACOLOGY | 1999年 / 42卷 / 1-3期
关键词
complement C3; C3 deficient mice; gene targeting; tissue-specific expression;
D O I
10.1016/S0162-3109(99)00021-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Genetic deficiencies of the complement protein C3 occur naturally in humans and animal models and have been induced in mice by targeted deletion of the C3 gene. The study of these deficiencies has provided evidence for C3 functions in immune responses. C3 deficient mice were generated by replacing the 5'-flanking region of the C3 gene with the neomycin-resistance (neo) gene. Serum from these mice had no detectable C3 protein or complement activity. Challenge with Streptococcus pneumoniae revealed approximately 2000-fold increase in bacteremia as compared to littermate controls. C3 mRNA was absent in the liver, but it was detected in the lung, kidney, fat tissue, heart and spleen. Metabolic labeling of the lung tissue and peritoneal macrophages showed synthesis of pro-C3, but no post-synthetic intracellular processing of the protein and no secretion of mature C3, cDNA analysis at the cap site indicated that extrahepatic transcription of the targeted gene was initiated in the neo cassette, close to the C3/neo junction and predicted a primary translation product lacking the leader peptide. The data indicate that these mice provide a good animal model for the study of complete C3 deficiencies and a potential probe for tissue-specific C3 gene regulatory elements. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:135 / 149
页数:15
相关论文
共 41 条
  • [1] AULT BH, 1994, IMMUNOLOGY, V81, P655
  • [2] BIOSYNTHESIS OF PRO-C3, A PRECURSOR OF 3RD COMPONENT OF COMPLEMENT
    BRADE, V
    HALL, RE
    COLTEN, HR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1977, 146 (03) : 759 - 765
  • [3] ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE
    CHIRGWIN, JM
    PRZYBYLA, AE
    MACDONALD, RJ
    RUTTER, WJ
    [J]. BIOCHEMISTRY, 1979, 18 (24) : 5294 - 5299
  • [4] CIRCOLO A, 1997, COMPLEMENT PRACTICAL, P199
  • [5] Colten H. R., 1993, COMPLEMENT HLTH DIS, P127, DOI DOI 10.1007/978-94-011-2214-6_4
  • [6] DASILVA EP, 1978, P NATL ACAD SCI USA, V75, P963, DOI 10.1073/pnas.75.2.963
  • [7] DEBRUIJN MHL, 1985, P NATL ACAD SCI USA, V82, P708
  • [8] AN IMPROVED SENSITIVE AND SIMPLE MICROASSAY OF MOUSE COMPLEMENT
    DEWAAL, RMW
    SCHRIJVER, G
    BOGMAN, MJJT
    ASSMANN, KJM
    KOENE, RAP
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1988, 108 (1-2) : 213 - 221
  • [9] FEY GH, 1994, PHIL T R SOC LONDON, V306, P333
  • [10] Fischer MB, 1996, J IMMUNOL, V157, P549